Examining the TCGA COAD/READ dataset, 77% of colorectal cancer has concurrent mutations in either two of three pathways: Wnt/b-catenin, RTK-RAS, or TP53 (Supplementary Fig. S6). Here, TP53 is linked to colorectal cancer.